Testosterone undecanoate - Organon

Drug Profile

Testosterone undecanoate - Organon

Alternative Names: Andriol; Androxon; Panteston; Restandol; Undestor; Virigen

Latest Information Update: 13 Feb 2014

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Organon
  • Class Anabolic steroids; Androstenols; Hormonal replacements; Small molecules; Testosterone congeners
  • Mechanism of Action Testosterone replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Marketed Hypogonadism

Most Recent Events

  • 05 Feb 2014 MSD Korea and Hanmi Pharmaceutical agree to co-promote testosterone undecanoate in South Korea for Hypogonadism
  • 19 Nov 2007 Organon has been acquired and merged into Schering-Plough
  • 15 Nov 1999 A modified form of Andriol® is undergoing phase III trials in the US and Europe
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top